Cortera earned FDA clearance in August and was introduced in a limited release, according to a news release. It is a posterior fixation platform designed based on feedback from spine surgeons. Cortera has modules for open and minimally invasive spine surgery.
Surgalign plans to further develop the Cortera, including integration with the Holo Portal guidance system. Cortera is Surgalisgn’s first organically developed product.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
